Oxidative stress and Alzheimer disease

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 33, 2005, Pages 117-119

  Ye, Jing ^a   Zhai, Hong Zhen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FREE RADICAL; MELATONIN;

AGING; ALZHEIMER DISEASE; HORMONE RELEASE; HUMAN; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; OXIDATIVE STRESS; PINEAL BODY; REVIEW; SENILE PLAQUE;

EID: 31544448295     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Multhaup G, Ruppert T, Schlicksupp A, et al. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 1997;54(5):533-9
2. Martins RN, Harper CG, Stokes GB, et al. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 1986;46(4):1042-5
3. Smith MA, Kutty RK, Richey PL, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994;145(1): 42-7
4. Hensley K, Hall N, Subramaniam R, et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995;65(5):2146-56
5. Sayre LM, Zelasko DA, Harris PL, et al. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68(5):2092-7
6. Smith MA, Richey Harris PL, Sayre LM, et al. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997;17(8):2653-7
7. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36(5):747-51
8. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336(17):1216-22
9. Bruce AJ, Malfroy B, Baudry M. beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci U S A 1996;93(6):2312-6
10. Smith MA, Hirai K, Hsiao K, et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 1998;70(5): 2212-5
11. Huang X, Atwood CS, Hartshorn MA, et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999;38(24):7609-16
12. Hensley K, Carney JM, Mattson MP et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A 1994;91(8):3270-4
13. Troncoso JC, Costello A, Watson AL et al. In vitro polymerization of oxidized tau into filaments. Brain Res 1993;613(2):313-6
14. Yan SD, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996;382(6593):685-91
15. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83-106
16. Marcus D, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998; 150(1):40-4
17. Chinese source. 2003, 18(6): 465-6
18. Chinese source. 2002, 10(4): 332-4
19. Marcus DL, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998; 150(1):40-4
20. Leon J, Acuna-Castroviejo D, Sainz RM, et al. Melatonin and mitochondrial function. Life Sci 2004;75(7):765-90
21. Beal FM. Aging, energy, and oxidative stress in neurodegenerative disease. Ann Neurol 1995;38(3)357-366
22. Gibson GL, Allsop D, Austen BM. Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's disease. Protein Pept Lett 2004; 11(3):257-70
23. Manson MP, Guo Q, Furukawa K, et al. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 1998; 70(1):1-14
24. Polidori MC. Oxidative stress and risk factors for Alzheimer's disease: clues to prevention and therapy. J Alzheimers Dis 2004;6(2):185-91
25. Good PF, Werner P, Hsu A, et al. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996;149(1):21-8
26. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer's. Nature 1996;382(6587):120-1
27. Bishop GM, Robinson SR. Physiological roles of amyloid -beta and implications for its removal in Alzheimer's disease. Drugs Aging 2004;21(10): 621-30
28. Gupta YK, Gupta M, Kohli K. Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian J Physiol Pharmacol 2003;47(4):373-86
29. Chinese source. 2002, 35(4): 212-5
30. Chinese source. β 2004, 8(34): 7712-3